Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer.

Cancer letters - 1 Feb 2014

Jobard Elodie, Pontoizeau Clément, Blaise Benjamin J, Bachelot Thomas, Elena-Herrmann Bénédicte, Trédan Olivier

Abstract excerpt

Breast cancer (BC) displays a high heterogeneity from histology to prognosis, metastatic evolution and treatment responses. We report here a (1)H NMR-based metabolic phenotyping study aiming at identifying coordinated metabolic serum changes associated with advanced metastatic breast cancer (MBC) in comparison to the localized early disease (EBC). A model discriminating EBC and MBC patients is obtained (n=85: 46...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Magnetic Resonance Spectroscopy

Share to Metabolomics

Share to Multivariate Analysis

Share to Neoplasm Metastasis

Share to ROC Curve

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 24041867
DOI: 10.1016/j.canlet.2013.09.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer.PMID 24041867Read ↗

Serum metabolome analysis by 1H-NMR reveals differences between chronic lymphocytic leukaemia molecular subgroups.Semantic proximity Read ↗

Integrated Metabolic and Gene Expression Profiling Reveals New Therapeutic Modalities for Rapidly Proliferating Breast CancersSemantic proximity Read ↗

Tissue-Based Metabolomics to Analyze the Breast Cancer Metabolome.Semantic proximity Read ↗

Magnetic Levitation Derived Metabolomic Fingerprinting Enables Exploratory Discrimination of Breast Cancer SubtypesSemantic proximity Read ↗

Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets.Semantic proximity Read ↗

Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types?Semantic proximity Read ↗

Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer IncidenceSemantic proximity Read ↗

Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells.Semantic proximity Read ↗

[Nuclear magnetic resonance based metabolic phenotyping for patient evaluations in operating rooms and intensive care units].Semantic proximity Read ↗

A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy.Semantic proximity Read ↗

Metabolomics in breast cancer: A decade in review.Semantic proximity Read ↗

MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.